Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DOCS NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCSDoximity$57.30-2.5%$58.39$25.00▼$85.21$10.76B1.372.35 million shs1.49 million shsTEMTempus AI$54.89-3.0%$62.47$31.36▼$91.45$9.80B4.998.16 million shs6.56 million shsAnalysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCSDoximity-2.46%-5.60%-3.40%-3.30%+104.65%TEMTempus AI-3.00%-14.89%-7.25%-3.80%+26.83%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDOCSDoximity3.6685 of 5 stars3.30.00.00.04.14.21.3TEMTempus AI2.4827 of 5 stars3.32.00.00.02.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCSDoximity 2.64Moderate Buy$64.8913.25% UpsideTEMTempus AI 2.50Moderate Buy$65.0918.58% UpsideCurrent Analyst Ratings BreakdownLatest DOCS, TEM, VTY, and RMG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025DOCSDoximityTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$52.00 ➝ $61.007/14/2025DOCSDoximityKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$65.00 ➝ $70.007/9/2025DOCSDoximityEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$50.00 ➝ $70.006/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.006/25/2025DOCSDoximityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $62.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $70.006/2/2025DOCSDoximityBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$80.005/27/2025DOCSDoximityJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$63.00 ➝ $60.005/21/2025DOCSDoximityThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetNeutral ➝ Neutral$80.00 ➝ $50.005/20/2025DOCSDoximityRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$87.00 ➝ $65.005/20/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $68.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCSDoximity$570.40M18.87$0.70 per share81.32$5.52 per share10.38TEMTempus AI$803.32M11.83N/AN/A$0.35 per share156.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCSDoximity$147.58M$1.1157.3053.554.1036.60%21.75%18.64%N/ATEMTempus AI-$705.81M-$7.80N/AN/AN/A-88.27%-533.21%-66.19%8/8/2025 (Confirmed)Latest DOCS, TEM, VTY, and RMG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q2 2025TEMTempus AI-$0.23N/AN/AN/A$296.84 millionN/A5/15/2025N/ADOCSDoximity$0.27$0.38+$0.11N/AN/AN/A5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDOCSDoximityN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCSDoximityN/A8.748.74TEMTempus AI2.451.711.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCSDoximity87.19%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipDOCSDoximity37.40%TEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDOCSDoximity890187.83 million116.87 millionNot OptionableTEMTempus AI2,400173.12 million125.34 millionN/ADOCS, TEM, VTY, and RMG HeadlinesRecent News About These CompaniesTEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMAugust 1 at 10:20 PM | prnewswire.comTempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?August 1 at 4:01 PM | zacks.comTempus AI (NASDAQ:TEM) Shares Down 3.6% - Here's WhyAugust 1 at 2:00 PM | marketbeat.comDeadline Alert: Tempus AI, Inc. (TEM) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitAugust 1 at 12:00 PM | globenewswire.comLiberty Mutual Group Asset Management Inc. Invests $1.17 Million in Tempus AI, Inc. (NASDAQ:TEM)August 1 at 8:01 AM | marketbeat.comCritical Survey: Tempus AI (NASDAQ:TEM) versus EUDA Health (NASDAQ:EUDA)August 1 at 2:04 AM | americanbankingnews.comTempus AI (TEM) Expected to Announce Quarterly Earnings on FridayAugust 1 at 2:14 AM | marketbeat.comTempus AI: Next Leg UpJuly 31 at 3:14 PM | seekingalpha.comTempus AI, Inc. (TEM) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 31 at 12:00 PM | prnewswire.comTEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your RightsJuly 31 at 10:44 AM | prnewswire.comTEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMJuly 31 at 10:24 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 31 at 10:00 AM | prnewswire.comTEM Investors Have Opportunity to Lead Tempus AI, Inc. Securities Fraud Lawsuit with the Schall Law FirmJuly 31 at 9:44 AM | prnewswire.comBanque Cantonale Vaudoise Takes Position in Tempus AI, Inc. (NASDAQ:TEM)July 31 at 7:45 AM | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 166,250 SharesJuly 31 at 6:02 AM | insidertrades.comThe Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo NordiskJuly 30 at 10:48 PM | theglobeandmail.comTempus AI: A Good Story At A Steep Price - Hold Until It Grows Into ItJuly 30 at 10:48 PM | seekingalpha.comTempus AI, Inc. (NASDAQ:TEM) CEO Sells $10,452,137.50 in StockJuly 30 at 10:31 PM | marketbeat.comTempus AI, Inc. (TEM) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 30 at 12:00 PM | prnewswire.comSkandinaviska Enskilda Banken AB publ Invests $1.01 Million in Tempus AI, Inc. (NASDAQ:TEM)July 30 at 7:41 AM | marketbeat.comTempus AI: Data‑Driven Margin Lift, But Cash Burn Extends My Hold StanceJuly 30 at 3:01 AM | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesSuper Micro Stock May Benefit as Cooling Demand Takes OffBy Gabriel Osorio-Mazilli | July 16, 2025View Super Micro Stock May Benefit as Cooling Demand Takes OffThese 2 Tech Stocks With 50%+ ROIC Are Built to Beat the MarketBy Leo Miller | July 24, 2025View These 2 Tech Stocks With 50%+ ROIC Are Built to Beat the Market3 Great Growth Stocks to Buy-and-Hold for the Next 10 YearsBy Chris Markoch | July 30, 2025View 3 Great Growth Stocks to Buy-and-Hold for the Next 10 YearsPEGA Surges 14%: There's Still Time to Ride This GenAI InnovatorBy Leo Miller | July 27, 2025View PEGA Surges 14%: There's Still Time to Ride This GenAI InnovatorBlock Levels Up: What S&P 500 Inclusion Means for InvestorsBy Jeffrey Neal Johnson | July 22, 2025View Block Levels Up: What S&P 500 Inclusion Means for InvestorsDOCS, TEM, VTY, and RMG Company DescriptionsDoximity NASDAQ:DOCS$57.30 -1.45 (-2.47%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$57.28 -0.02 (-0.04%) As of 08/1/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Tempus AI NASDAQ:TEM$54.89 -1.70 (-3.00%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$54.72 -0.16 (-0.30%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
